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Abstract
Background: Acute kidney injury (AKI) is a common clinical syndrome with poor prognosis. The insensitivity and
non-specificity of traditional markers of renal dysfunction prevent timely estimation of the severity of renal injury,
and the administration of possible therapeutic agents. Urinary kidney injury molecule-1 (uKIM-1) is a marker of
epithelial injury of renal tubules. Different uKIM-1 levels are associated with various degrees of renal injury. This
study sought to evaluate uKIM-1 as a predictor of renal prognosis by analyzing uKIM-1 levels in patients with AKI.
Methods: A total of 258 patients were screened, 201 patients were enrolled in the study, and 17 patients were lost
to follow up. Therefore, 184 AKI patients were included in this study and were classified into transient AKI and renal
AKI groups according to short-term renal function recovery (48 h). Changes in renal function were observed for one
year during regular follow up, and risk factors that affected renal prognosis were analyzed.
Results: The uKIM-1 level in the renal AKI group was significantly higher than that in the transient AKI group.
The receiver operating characteristic area under the curve (ROC-AUC) of uKIM-1 for the diagnosis of renal AKI was
0.691, and its sensitivity and specificity were 66.3 % and 64.7 %, respectively. The uKIM-1 level at AKI occurrence
was significantly higher in the group with deterioration in renal function than in the group with stable renal
function. Thus, uKIM-1 level is a prognostic factor for poor renal prognosis. ROC curve analysis demonstrated that
the AUC for the prediction of renal function progression on the basis of uKIM-1 levels in patients with renal AKI
and AKI was 0.680 and 0.703, respectively; the sensitivity was 78.6 % and 78.4 %, respectively; and the specificity
was 57.9 % and 60.8 %, respectively. uKIM-1 > 2.37 ng/mg in patients with AKI positively correlated with poor
renal prognosis.
Conclusions: uKIM-1 levels sensitively predict the renal prognosis of patients with AKI, and they may be used as
early screening indicators for poor renal prognosis.
Keywords: Acute kidney injury, Urine kidney injury molecule-1, Renal AKI, Transient AKI, Long-term outcomes
Abbreviations: AKI, Acute kidney injury; CKD, Chronic kidney disease; eGFR, Estimated glomerular filtration rate;
ESRD, End-stage renal disease; FeNa, Fractional excretion of sodium; RFI, Renal failure index; ROC-AUC, Receiver
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Background
Acute kidney injury (AKI) is one of a number of conditions
that affect kidney structure and function. AKI is defined by
an abrupt decrease in kidney function. It is a broad clinical
syndrome encompassing various types of etiology [1]. AKI
has a high incidence rate, and it is an increasingly common
complication associated with poor prognosis in hospi-
talized patients. AKI consumes a large amount of social
and medical resources, but there is a shortage of effective
therapeutic regimens [2, 3]. The kidney normally exhibits
an extremely strong capacity for self-regeneration and re-
pair, and can recover from mild and moderate injury [4].
However, incomplete renal repair can result in chronic
kidney disease (CKD) in some cases [4, 5]. In recent years,
the incidence rate of CKD has annually increased with the
increasing incidence rate of AKI [6]. Numerous studies
have found that renal function in some patients with AKI
does not recover completely but gradually progresses to
CKD and end-stage renal disease (ESRD), and may require
permanent renal replacement therapy [2, 6, 7]. Urinary kid-
ney injury molecule-1 (uKIM-1) is a marker of epithelial
injury of renal tubules, and it is elevated in the early stages
of AKI [8]. Different uKIM-1 levels are associated with
various degrees of renal injury. This study examined
the value of uKIM-1 level in identifying reversible renal
injury and its predictive value for long-term prognosis
by examining renal function recovery during short-
term and long-term prognoses in patients with AKI.
Methods
Study subjects
Male and female inpatients ≥18 years of age with
complete clinical data who were diagnosed with AKI or
acute-on-chronic kidney injury (A on C) were enrolled
in this study. Minor patients and patients with a life ex-
pectancy less than one year because of malignant disease
were excluded. AKI was defined and staged using the
Kidney Disease Improving Global Outcomes (KDIGO)
Clinical Practice Guidelines for Acute Kidney Injury [1].
Our study was conducted at Renji Hospital, School of
Medicine, Shanghai Jiaotong University, Shanghai, P.R.
China, a 2000-bed teaching hospital. The subjects were
recruited from all hospital departments (both surgical
and non-surgical), including ICU.
Sampling
Fresh urine and blood samples were obtained from each
patient at the time of AKI diagnosis and at 24 h and
48 h, and at the 3-month, 6-month, and 12-month
follow up, and they were submitted to a biochemical
laboratory for analysis. Fresh urine (10 ml) collected
from each patient at the time of AKI diagnosis was
centrifuged at 1000 × g for 15 minutes, and the liquid
supernatant was placed into Eppendorf tubes and stored
at -80 °C until subsequent analysis.
Detection of indicators
Serum creatinine (sCr) and urine creatinine (uCr) were
detected using enzymatic methods. A simplified formula
for the modification of diet in renal disease (MDRD) was
used to calculate the estimated glomerular filtration rate
(eGFR):
eGFR = 186 × (sCr/88.4)‐ 1.154 × Age‐ 0.203 × (0.742,
Female) [9].
An enzyme-linked immunosorbent assay (ELISA) was
performed to detect urine kidney injury molecule-1
Fig. 1 Study flow chart. AKI acute kidney injury
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(uKIM-1) using a kit from the American R&D Corporation
(Minneapolis, MN, USA). The concentration of the tested
sample was calculated using a standard curve, and the
results are expressed in ng/mg after synchronous uCr cor-
rection. Fractional excretion of sodium (FeNa) was calcu-
lated as follows:
FeNa ¼ Plasma creatinine  Urinary Nað Þ
 Plasma Na  Urinary creatinineð Þ:
The renal failure index (RFI) was calculated as follows:
RFI ¼ Urinary Na  Plasma creatinineð Þ=Urinary creatinine:
Grouping
Patients with AKI were divided into transient AKI and
renal AKI groups according to changes in renal function
within 48 h. Transient AKI was defined as a reversal
within 48 h [10]. Renal AKI was defined as non-transient
AKI when no recovery was observed within 48 h [10].
Recovery of AKI was determined as reduction of serum
creatinine from the peak to less than 0.3 mg/dl above
baseline [10]. We also corrected sCr for fluid balance [11].
No patients received blood transfusions.
Patients with AKI and patients with renal AKI patients
were classified into two groups during one year of follow
up: a group with stable renal function and a group with
deterioration in renal function. Deterioration in renal
function was defined as a one-stage reduction in GFR
accompanied by a 25 % or greater reduction in eGFR
from baseline [12].
Statistical analysis
SPSS13.0 statistical software IBM (NY, USA) was used.
Normally distributed measurement data are expressed as
mean ± sd, and the t test was used for group compari-
sons. Measurement data with a non-normal distribution
are expressed as the median (M) and interquartile range
(P25, P75). The rank sum test was used for comparisons
between groups. Spearman correlation analysis was used
to analyze correlations. A receiver operating characteristic
(ROC) curve and the area under curve were used to
calculate the sensitivity and specificity. Logistic regres-
sion analysis was used to analyze related risk factors
that influenced the prognosis of kidney function. Cox
multifactor regression analysis was used to analyze the
relationship between all risk factors and the life span of
the kidneys. Survival rate was analyzed using a Kaplan-




A total of 258 patients were screened, 201 patients were
enrolled in the study, and 17 patients were lost to follow
up. Therefore, 184 patients with AKI (86 patients with
transient AKI and 98 patients with renal AKI) were in-
cluded in the study. All the 184 patients survived to
one-year follow up. After regular follow up for one year,
Table 1 General condition of patients
Characteristics Values (n = 184 patients)
Age, years 53.00 (31.00, 64.75)
Male sex (n, %) 117 (63.59 %)
Oliguria (n, %) 9 (4.9 %)
Baseline serum creatinine (mg/dl) 1.12 (0.87, 2.40)
Baseline estimated GFR (ml/min/1.73 m2) 66.68 (28.10, 94.18)
Baseline 24 hUTP (g/24 h) 3.78 (1.47, 9.08)
sAlb (g/l) 33.30 (24.00, 40.25)
Hb (g/l) 119.00 (99.25, 140.00)
ALT (IU/l) 14.00 (10.00, 23.00)
AST (U/l) 17.00 (14.00, 25.75)
Ca (mmol/l) 2.08 (1.99, 2.22)
P (mmol/l) 1.32 (1.10, 1.56)
K (mmol/l) 3.90 (3.40, 4.30)
HCO3
- (mmol/l) 24.20 (20.90, 26.40)
hsCRP (mg/l) 2.40 (0.80, 8.17)
Cause of AKI (n (%)
Ischemia 40 (21.74 %)
Nephrotoxicity 37 (20.11 %)
Infection 42 (22.83 %)
Glomerular disease 35 (19.02 %)
Obstruction 21 (11.41 %)





Peak serum creatinine (mg/dl) 2.43 (1.41, 3.74)
uKIM-1 (ng/mg) 2.37 (1.10, 6.22)
FeNa ≥1 % (n (%)) 126 (68.48 %)
RFI ≥1 % (n (%)) 136 (73.91 %)
Renal AKI (n (%)) 98 (53.26 %)
Progression of renal failure (n (%)) 73 (39.67 %)
Conversion factor for serum creatinine in mg/dL to mmol/L, ×88.4. AKI acute
kidney injury, GFR glomerular filtration rate, UTP urinary protein excretion, sAlb
serum albumin, Hb hemoglobin, ALT alanine aminotransferase, AST aspartate
aminotransferase, Ca calcium, P phosphorus, K potassium, HCO3
- , bicarbonate,
hsCRP high-sensitivity C-reactive protein, uKIM-1 urinary kidney injury
molecule-1, FeNa fractional excretion of sodium, RFI renal failure index
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111 of the 184 patients were in the stable renal function
group, and 73 patients were in the renal function deterior-
ation group. Of the 98 patients with renal AKI, 49 were in
the stable renal function group, and 49 were in the renal
function deterioration group (Fig. 1).
Of the 184 patients with AKI, the ages ranged from 18
to 99 years, and the median age was 53.00 (31.00, 64.75)
years. The male/female ratio was 1.75:1, and the mean
follow-up duration was 12.2 ± 1.06 months. The basic
serum creatinine (sCr), basic eGFR and basic 24-h total
urine protein levels were 1.12 (0.87, 2.40) mg/dl, 66.68
(28.10, 94.18) ml/min/1.73 m2 and 3.78 (1.47, 9.08) g,
respectively. The baseline creatinine was considered the
lowest value within 3 months prior to diagnosis of AKI.
There were 71 patients with previous chronic renal
disease (CKD). CKD is defined according to Kidney
Disease Improving Global Outcomes (KDIGO) Clinical
Practice Guidelines for the Evaluation and Management
of Chronic Kidney Disease [12]. The uKIM-1 level at
the time of AKI occurrence was 2.37 (1.10, 6.22) ng/mg,
and the peak level of creatinine was 2.43 (1.41, 3.74) mg/dl.
There were 123 patients in AKI stage I, 26 patients in
stage II and 35 patients in stage III. Patients with renal
AKI accounted for 53.26 %. The clinical etiology of AKI
included insufficient renal blood perfusion or ischemia
(22 %) (insufficient volume, gastrointestinal loss, cardiac
failure, or renal vascular factors), nephrotoxicity (20 %)
(nephrotoxic agents and contrast medium injury, etc.), in-
fection factor (23 %) (sepsis, severe pneumonia and any
kind of infection that caused renal injury), aggravation or
activation of glomerular disease (19 %), and obstruction
(11 %). The proportion of patients with renal function
progression was 39.67 % at the one-year follow up
(Table 1).
Fig. 2 Western blot analysis of urinary kidney injury molecule-1 (uKIM-1) with and without established acute kidney injury (AKI). All patients with
established AKI had easily detectable uKIM-1. The uKIM-1 levels in urine from patients who were clinically diagnosed with renal AKI were higher
than in patients with transient AKI: *P < 0.05, **P < 0.001. CKD chronic kidney disease
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Fig. 3 Spearman correlation analyses. a The urinary kidney injury molecule-1 (uKIM-1) content was positively correlated with fractional excretion
of sodium (FeNa). b. The uKIM-1 content was positively correlated with the renal failure index (RFI). c. The uKIM-1 content was positively correlated
with the times of creatinine elevation
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uKIM-1 detection by western blot
Western blot analysis was performed on urine specimens
from six patients: two patients were clinically diagnosed
with renal AKI, two patients were clinically diagnosed
with transient AKI, one was a patient with CKD, and one
patient was used as a normal control. uKIM-1 was un-
detectable in healthy control urine, and a low level was
observed in the urine of the patient with CKD. In sharp
contrast, all patients with established AKI had easily de-
tectable levels of uKIM-1, and higher levels were observed
in urine from patients who were clinically diagnosed with
renal AKI (Fig. 2).
Correlation analysis
Spearman correlation analysis indicated that uKIM-1
positively correlated with the fractional excretion of so-
dium (FeNa), renal failure index (RFI) and creatinine ele-
vation (r = 0.887, 0.887 and 0.438, respectively, P = 0.000)
(Fig. 3).
Identification of transient AKI and renal AKI on the basis
of uKIM-1 levels
The patients were classified into transient AKI (86 patients)
and renal AKI groups (98 patients) on the basis of renal
function recovery during short-term follow up (≤48 h).
Comparisons between groups demonstrated that the prog-
nosis of the renal AKI group was significantly inferior to
the transient AKI group. Of the 86 patients with transient
AKI, 44 presented with a FeNa ≥1 %, and 48 presented
with an RFI ≥1 %. Comparisons between groups indicated
that the uKIM-1 level of the renal AKI group was signifi-
cantly higher than that of the transient AKI group (Table 2,
Fig. 4).
ROC curve analysis revealed that the area under the
curve (ROC-AUC) was 0.691 (P = 0.000) for the diagno-
sis of renal AKI on the basis of uKIM-1. The sensitivity
was 66.3 % when the cutoff point of uKIM-1 level was
2.14 ng/mg, and the specificity was 64.7 % (Fig. 5).
Analysis of long-term prognosis predictions on the basis
of uKIM-1 levels
Analysis of long-term prognosis for patients with renal AKI
Of the 98 patients with renal AKI at the regular one-year
follow up, 49 were in the stable renal function group, and
49 were in the renal function deterioration group. There
was no difference by sex in the composition of the groups.
However, patients in the renal function deterioration
group were older than those in the renal function stable
group, and their basic renal function was inferior, with a
high peak value of creatinine after AKI. More patients in
the renal function deterioration group presented with
FeNa ≥1 % and RFI ≥1 %, and their uKIM-1 levels were
significantly higher than the stable renal function group
(Table 3).
Gradual Cox regression analysis indicated that patients
with renal AKI had higher uKIM-1 levels with poorer
long-term renal prognosis. The risk of renal function de-
terioration following AKI increased by 6.4 % for each
1 ng/mg increase in uKIM-1. The prognosis of patients
with renal AKI who presented with FeNa ≥1 % was in-
ferior to that of patients with FeNa <1 % (Table 4).
The ROC-AUC for the prediction of renal function de-
terioration in patients with renal AKI when the uKIM-1
level was 0.680. When the cutoff for uKIM-1 was
2.46 ng/mg, the sensitivity was 78.6 %, and the specifi-
city 57.9 % (Fig. 6). The K-M curve indicated that
uKIM-1 > 2.46 ng/mg positively correlated with poor
long-term renal prognosis in patients with renal AKI
(P = 0.000) (Fig. 7).
Analysis of long-term prognosis for patients with AKI
Of the 184 patients with AKI after the regular one-year
follow up, 111 patients were in the stable renal function







uKIM-1 (ng/mg) 1.52 (0.57, 4.29) 3.24 (1.56, 8.53) 0.000
FeNa ≥1 % (n (%)) 44 (51.16 %) 82 (83.67 %) 0.000
RFI ≥1 % (n (%)) 48 (55.81 %) 88 (89.80 %) 0.000
Progression of renal
failure (n (%))
24 (27.91 %) 49 (50.00 %) 0.000
AKI acute kidney injury, uKIM-1 urinary kidney injury molecule-1, FeNa fractional
excretion of sodium, RFI renal failure index
Fig. 4 The urinary kidney injury molecule-1 (uKIM-1) levels in the
transient acute kidney injury (AKI) group were significantly higher
than those of the renal AKI group
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group, and 73 patients were in the renal function deteri-
oration group. There was no difference by sex in the
composition of the groups. However, patients in the
renal function deterioration group were older than pa-
tients in the stable renal function group, and their basic
renal function was inferior, with a high peak value of cre-
atinine following AKI. More patients in the renal function
deterioration group presented with FeNa ≥1 % and
RFI ≥1 %, and the uKIM-1 level was significantly higher
than that of the stable renal function group (Table 5).
Gradual Cox regression analysis indicated that older
patients had lower basic eGFR, higher uKIM-1, and
poorer long-term renal prognosis. The risk of renal func-
tion deterioration after AKI increased by 3.3 % for each
one-year increase in age. The risk of renal function
deterioration after AKI increased by 2.4 % for each
Fig. 5 Receiver operating characteristic area under the curve (ROC-AUC) of renal acute kidney injury according to urinary kidney injury molecule-1
(uKIM-1) level
Table 3 Comparison between the renal function deterioration group and the stable renal function group after one-year follow up
in patients with renal acute kidney injury
Characteristics Stable renal function (n = 49) Renal function deterioration (n = 49) P
Age, years 53.00 (32.75, 65.00) 62.00 (45.00, 72.00) 0.039
Male sex, (n (%)) 30 (61.22 %) 31 (63.27 %) 1.000
Baseline serum creatinine (mg/dl) 1.12 (0.87, 1.88) 2.23 (1.11, 3.13) 0.006
Baseline estimated GFR (ml/min/1.73 m2) 74.00 (39.31, 92.33) 30.52 (17.01, 53.93) 0.001
Baseline 24 hUTP (g/24 h) 6.12 (2.13, 9.34) 5.32 (1.58, 9.48) 0.563
Peak serum creatinine (mg/dl) 2.20 (1.49, 3.63) 3.43 (2.44, 4.51) 0.002
uKIM-1 (ng/mg) 2.05 (1.17, 6.33) 5.15 (2.48, 11.06) 0.006
FeNa ≥1 % (n (%)) 26 (53.06 %) 44 (89.80 %) 0.000
RFI ≥1 % (n (%)) 32 (65.31 %) 47 (95.92 %) 0.000
Conversion factor for serum creatinine in mg/dL to mmol/L, ×88.4. GFR glomerular filtration rate, UTP urinary protein excretion, uKIM-1 urinary kidney injury
molecule-1, FeNa fractional excretion of sodium, RFI renal failure index
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decrease of 1 ml/min/1.73 m2 of basic eGFR. The risk of
renal function deterioration after AKI increased by 1.8 %
for each 1 ng/mg increase in uKIM-1 (Table 6).
The ROC-AUC values for the prediction of renal func-
tion deterioration with age, uKIM-1 level and basic
eGFR level were 0.687, 0.703 and 0.833, respectively.
When the age cutoff point was 59.5 years, the sensitivity
was 54.1 %, and the specificity 78.4 %. When the cutoff
point of the uKIM-1 level was 2.37 ng/mg, the sensitivity
was 78.4 %, and the specificity 60.8 %. When the cutoff
point of the eGFR level was 60.35 ml/min/1.73, the sensi-
tivity and specificity were 71.2 % and 76.3 %, respectively
(Fig. 8).
The K-M curve revealed that uKIM-1 > 2.37 ng/mg
positively correlated with poor long-term renal prognosis
(P = 0.000) (Fig. 9).
Discussion
The incidence rate of AKI is high, and is showing a
trend of annual increase. AKI is common in hospitalized
patients, especially critical patients; critical patients with
AKI have high mortality rates. Recent epidemiological
data have indicated that even mild and reversible AKI
leads to persistent injuries of renal tissues, and severe
AKI results in an irreversible decrease in renal function,
which increases the risk of death. Several observational
Table 4 Cox regression shows the independent risk factors for renal function progression in patients with renal acute kidney injury
Univariate analysis Multivariate analysis
Characteristics Relative risk P Relative risk P
Age, years 1.025 (1.006, 1.044) 0.009
Male sex
Baseline estimated GFR (ml/min/1.73 m2) 0.974 (0.959, 0.990) 0.001
Peak serum creatinine (mg/dl) 1.002 (1.000, 1.003) 0.009
uKIM-1 (ng/mg) 1.064 (1.036, 1.093) 0.000 1.064 (1.024, 1.106) 0.001
FeNa ≥1 % 4.510 (1.588, 12.806) 0.005 9.538 (1.264, 72.006) 0.029
RFI ≥1 % 5.486 (1.311, 22.945) 0.020
GFR glomerular filtration rate, uKIM-1 urinary kidney injury molecule-1, FeNa fractional excretion of sodium, RFI renal failure index
Fig. 6 Receiver operating characteristic area under the curve (ROC-AUC) of renal function progression in patients with renal acute kidney injury
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studies have demonstrated that acute renal injuries are
significantly correlated with the subsequent development
of chronic renal disease [13]. For example, many obser-
vational studies have demonstrated that some renal func-
tion is often recovered in a large proportion of patients
with acute renal injury and patients without previous renal
disease, but symptoms in these patients subsequently de-
velop end-stage chronic renal disease. However, the long-
term prognosis of AKI is not clear, and markers of early
AKI prognosis are lacking.
This study followed 184 patients with AKI of different
etiological types, and found that nearly 40 % of patients
presented with deterioration in renal function after one
year. On further analysis of these patients with AKI, 86
patients had recovered renal function within short-term
follow up (within 48 h) and 98 patients did not recover
renal function: 50 % of patients who did not recover
renal function within 48 h had renal function deterior-
ation within one year. Previous studies [14, 15] have also
demonstrated that AKI results in CKD and affects the
course of CKD. AKI is generally reversible when serum
creatinine concentrations recover, but there may be sub-
clinical injury of the kidney and other organs, resulting
in CKD and ESRD.
Methods that indicate the prognosis of AKI during
early stages are lacking. Basic studies [16, 17] have
demonstrated that renal ischemia reperfusion injury
alters the permeability of endothelial cells, decreases
blood capillaries around the tubules, and creates an
oxygen deficiency around the tubules and in the tissue
space, which eventually results in fibrosis and gradually
changes the kidney structure. Therefore, these patients
develop CKD more easily. KIM-1 is an outstanding
marker of renal injury [18], and KIM-1 is increased in
Fig. 7 Urinary kidney injury molecule-1 (uKIM-1) level and kidney prognosis in patients with renal acute kidney injury patients. uKIM-1 > 2.46 ng/mg
was positively related to poor prognosis. Cum cumulative
Table 5 Comparison between the renal function deterioration group and the stable renal function group after one-year follow up
in patients with acute kidney injury
Characteristics Stable renal function (n = 111) Renal function deterioration (n = 73) P
Age, years 42.00 (29.00, 59.00) 59.00 (45.00, 71.00) 0.000
Male sex 73 (65.77 %) 44 (60.27 %) 0.531
Baseline serum creatinine (mg/dl) 0.96 (0.76, 1.32) 2.17 (0.99, 3.22) 0.000
Baseline estimated GFR (ml/min/1.73 m2) 84.39 (50.57, 111.86) 31.21 (17.09, 61.04) 0.000
Baseline 24 hUTP (g/24 h) 3.38 (1.44, 8.83) 2.23 (1.48, 9.06) 0.802
Peak serum creatinine (mg/dl) 1.92 (1.27, 3.04) 3.43 (2.31, 4.63) 0.000
uKIM-1 (ng/mg) 1.57 (0.70, 3.89) 4.41 (1.69, 8.72) 0.000
FeNa ≥1 % (n (%)) 61 (54.95 %) 65 (89.04 %) 0.000
RFI ≥1 % (n (%)) 71 (63.96 %) 65 (89.04 %) 0.000
GFR glomerular filtration rate, UTP Urinary protein excretion, uKIM-1 urinary kidney injury molecule-1, FeNa fractional excretion of sodium, RFI renal failure index
Xie et al. Critical Care  (2016) 20:286 Page 9 of 12
prerenal AKI. KIM-1 increases significantly in renal AKI
[19]. The fractional excretion of FeNa and the RFI are
often used to define renal AKI, but there are certain
limitations [20]. This study demonstrated that uKIM-1
was significantly increased in patients with renal AKI.
The ROC-AUC indicated that high uKIM-1 was valuable
in the diagnosis of renal AKI. Thus, high uKIM-1 indi-
cates a high possibility of severe renal injury.
In previous studies of obstructive nephropathy [21, 22],
uKIM-1 in patients with deterioration of renal function
were significantly higher than in patients with stable renal
function among patients with obstructive nephropathy
who developed AKI. After one year, uKIM-1 in the pa-
tients with deterioration in renal function was significantly
higher than that patients with stable renal function in 90
patients with obstructive nephropathy, regardless of
Table 6 Cox regression shows the independent risk factors for renal function progression in patients with acute kidney injury
Univariate analysis Multivariate analysis
Characteristics Relative risk P Relative risk P
Age, years 1.033 (1.018, 1.047) 0.000 1.032 (1.008, 1.057) 0.009
Male sex
Baseline estimated GFR (ml/min/1.73 m2) 0.976 (0.965, 0.987) 0.000 0.974 (0.962, 0.986) 0.000
Peak serum creatinine (mg/dl) 1.002 (1.001, 1.003) 0.001
uKIM-1 (ng/mg) 1.018 (1.008, 1.029) 0.000 1.018 (1.004, 1.031) 0.009
FeNa ≥1 % 3.314 (1.622, 6.768) 0.001
RFI ≥1 % 2.670 (1.199, 5.948) 0.016
GFR glomerular filtration rate, uKIM-1 urinary kidney injury molecule-1, FeNa fractional excretion of sodium, RFI renal failure index
Fig. 8 Receiver operating characteristic area under the curve (ROC-AUC) of renal function progression in patients with acute kidney injury.
uKIM-1 urinary kidney injury molecule-1, GFR glomerular filtration rate
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their AKI status, which indicates that uKIM-1 has a
predictive value in the long-term prognosis of patients
with obstructive nephropathy. A large clinical study
[23] performed renal puncture biopsy in patients with
renal disease of different etiological types and demon-
strated that KIM-1 is secreted in proximal renal tubular
epithelial cells; further, the tissue expression of KIM-1
is associated with fibrosis and inflammation. uKIM-1
reflects KIM-1 levels in tissues, which is related to renal
tubulointerstitial inflammation and renal function. This
relationship indicates that KIM-1 is not only a bio-
logical marker of acute renal proximal tubular injury
but also a marker of tubulointerstitial chronic inflam-
mation and fibrosis [24].
This study demonstrated that uKIM-1 levels in the
renal function deterioration group were significantly
higher than those in the stable renal function group in
patients with renal AKI after a regular one-year follow
up. The risk of renal function deterioration following
AKI increased by 6.4 % for each 1 ng/mg increase in
uKIM-1. Analysis of the ROC curve indicates that the
uKIM-1 level better predicted the long-term prognosis
of patients with renal AKI. We further analyzed the 184
included patients with AKI, and the results indicated
that uKIM-l in the renal function deterioration group
was significantly higher than that in the stable renal
function group. Age, basic eGFR, and uKIM-1 were risk
factors for poor renal prognosis. The K-M curve demon-
strated that uKIM-1 > 2.37 ng/mg positively correlated
with poor long-term renal prognosis. Our study indi-
cates that uKIM-1 better predicts the long-term progno-
sis of patients with AKI.
This was a single-center study with a small sample
size; changes in renal function were followed up for one
year, but no further follow up was performed to identify
changes in marker levels. Therefore, a larger, multi-
center study is required to verify the results of this study,
and follow up must be performed to detect changes in
marker levels during the progression of renal diseases, to
further prove the value of uKIM-1 for the monitoring of
renal prognosis.
Conclusions
The prognosis of patients with AKI is poor, and there is
a risk of renal function progression. High uKIM-1 indi-
cates a high possibility of severe renal injury. uKIM-1 ac-
curately predicted the renal prognosis of patients with
AKI, and they may be used as an early screening indica-
tor of poor renal prognosis. The results of this study
suggest novel treatment strategies and may help clinical
physicians to engage in early interventions to slow the
progression of renal deterioration after AKI.
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